Gene · 9846
Papers1,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,533
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review. | Front Immunol | 2023 | 37475866 | PubTator, text mining | PubMed |
| An intramolecular energetic network regulates ligand recognition in a SH2 domain. | Protein Sci | 2023 | 37468946 | PubTator, text mining | PubMed |
| Case report: Chorea and cognitive decline in a young woman: instrumental and genetic assessment of a case originally diagnosed as multiple sclerosis. | Front Genet | 2023 | 37434948 | PubTator, text mining | PubMed |
| A narrative review about CDK4/6 inhibitors in the setting of drug resistance: updates on biomarkers and therapeutic strategies in breast cancer. | Transl Cancer Res | 2023 | 37434680 | PubTator, text mining | PubMed |
| m6A mRNA Methylation Analysis Provides Novel Insights into Pigmentation in Sheep Skin. | Epigenetics | 2023 | 37389979 | PubTator, text mining | PubMed |
| Retracted: Association of GAB2 with Quality of Life and Negative Emotions in Patients with Gastric Cancer after Postoperative Comprehensive Care. | Evid Based Complement Alternat Med | 2023 | 37387851 | PubTator, text mining | PubMed |
| PPAD: a deep learning architecture to predict progression of Alzheimer's disease. | Bioinformatics | 2023 | 37387135 | PubTator, text mining | PubMed |
| CXCL8 and the peritoneal metastasis of ovarian and gastric cancer. | Front Immunol | 2023 | 37377954 | PubTator, text mining | PubMed |
| Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy. | Pharmaceutics | 2023 | 37376140 | PubTator, text mining | PubMed |
| Vascular Inflammatory Diseases and Endothelial Phenotypes. | Cells | 2023 | 37371110 | PubTator, text mining | PubMed |
| Small RNA modifications: regulatory molecules and potential applications. | J Hematol Oncol | 2023 | 37349851 | PubTator, text mining | PubMed |
| TCGA Expression Analyses of 10 Carcinoma Types Reveal Clinically Significant Racial Differences. | Cancers (Basel) | 2023 | 37345032 | PubTator, text mining | PubMed |
| Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells. | mBio | 2023 | 37341489 | PubTator, text mining | PubMed |
| Genetic and epigenetic background of diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | 37324271 | PubTator, text mining | PubMed |
| LncRNA NEAT1 Promotes Vascular Endothelial Cell Dysfunction via miR-218-5p/GAB2 and Serves as a Diagnostic Biomarker for Deep Vein Thrombosis. | Clin Appl Thromb Hemost | 2023 | 37321605 | PubTator, text mining | PubMed |
| Analyses of Genes Critical to Tumor Survival Reveal Potential 'Supertargets': Focus on Transcription. | Cancers (Basel) | 2023 | 37297004 | PubTator, text mining | PubMed |
| Competing endogenous RNA analysis identified lncRNA DSCR9 as a novel prognostic biomarker associated with metastasis and tumor microenvironment in renal cell carcinoma. | Oncol Lett | 2023 | 37274469 | PubTator, text mining | PubMed |
| Experiment-guided molecular simulations define a heterogeneous structural ensemble for the PTPN11 tandem SH2 domains. | Chem Sci | 2023 | 37265738 | PubTator, text mining | PubMed |
| Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review. | Molecules | 2023 | 37241729 | PubTator, text mining | PubMed |
| Preparation of Waste PP/Fly Ash/Waste Stone Powder Composites and Evaluation of Their Mechanical Properties. | Materials (Basel) | 2023 | 37241314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9846/papers?page=6